Eversheds Sutherland advises PHSE on its cross-border acquisition of Moving Forward International

PHSE is a leading group in temperature-controlled and time-critical pharmaceutical logistics, focusing on the logistical management of clinical trials and active temperature-controlled shipping (Active Cool Chain) for pharmaceuticals, biotech, biological samples, and clinical trials. They serve the hospital, home care, and clinical research channels.

Moving Forward International, a German freight forwarding company, specializes in demanding logistics, handling hazardous and sensitive goods, including the transport of radiopharmaceuticals and other pharmaceutical products by road and air. The acquisition of Moving Forward International provides PHSE with entry into Germany, Europe’s leading pharmaceutical market.

The international Eversheds Sutherland team for this cross-border transaction included the partners Davide Proverbio (Milan, Italy) and Sandra Link (Frankfurt, Germany), associate Giuseppe Angiulli (Milan, Italy) as well as senior associate Sabrina Rübsam and associate Rebecca Flachs Nóbrega(both Frankfurt, Germany).